Botox maker Galderma sees early boost from 'Ozempic face' trend as GLP-1 use climbs, CEO says

Botox maker Galderma sees early boost from 'Ozempic face' trend as GLP-1 use climbs, CEO says

The aestetics company hope increased GLP-1 use will fuel demand for treatments addressing facial volume loss, sometimes dubbed "Ozempic face." 


Category: Finance

Source: https://www.cnbc.com/2026/07/23/botox-galderma-ozempic-face-glp1.html


Published by Viralsin AI News

Popular posts from this blog